The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors associated with response to neoadjuvant chemotherapy and immune checkpoint inhibition in triple-negative breast cancer.
 
Alexis LeVee
No Relationships to Disclose
 
Megan Wong
No Relationships to Disclose
 
Sarah Flores
No Relationships to Disclose
 
Nora H. Ruel
No Relationships to Disclose
 
Sayeh Moazami Lavasani
Consulting or Advisory Role - Puma Biotechnology
Speakers' Bureau - Seagen
 
Niki Patel
Honoraria - OncLive Clinical Congress Consultants; OncLive/MJH Life Sciences
Consulting or Advisory Role - Node.Health
 
Mina S. Sedrak
Research Funding - Lilly (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst)
 
Daphne B. Stewart
No Relationships to Disclose
 
James Ross Waisman
No Relationships to Disclose
 
Yuan Yuan
Consulting or Advisory Role - BCI Pharma; Diiachi; Eisai; Genentech; Guardant Health; Immunomedics; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Genentech; Gilead Sciences; Merck; Pfizer
Research Funding - Genentech; Imugene; Merck; Novartis; Pfizer
Expert Testimony - Novartis
 
Joanne E. Mortimer
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; Puma Biotechnology